home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc. From 05/03/22

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022. Following the release, the Company will ho...

AGRX - PAVM, TBLT and ISPC among mid-day movers

Gainers: Vivakor (VIVK) +91%. Digital World Acquisition (DWAC) +33%. Studio City International Holdings (MSC) +31%. Tempest Therapeutics (TPST) +30%. PAVmed  (PAVM) +17%. AppTech Payments (APCX) +16%. Priority Technology Holdings (PRTH) +14%. Fusion Pharmaceuticals (FUSN) +14%. Alkermes ...

AGRX - Nutex, Repligen top healthcare gainers; Molecular Partners, Agile lead losers' pack

Gainers: Nutex Health (NUTX) +24%. Repligen (RGEN) +14%. Zentalis Pharmaceuticals (ZNTL) +14%. Alkermes (ALKS) +12%. Clever Leaves (CLVR) +8%. Losers: Molecular Partners (MOLN) -37%. Agile Therapeutics (AGRX) -28%. Immunome (IMNM) -1...

AGRX - Agile Therapeutics to raise $13M in stock offering, provides certain Q1 estimates and reverse stock split effective Apr.27

Agile Therapeutics (NASDAQ:AGRX) entered into a sales agreement to sell up to $12.84M of shares of stock, par value $0.0001/share, through a sales agent. The company cannot provide any assurance that it will issue any shares of its common stock post to the sales agreement. Concurrently, the c...

AGRX - BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics ...

AGRX - Hot Penny Stocks to Buy Today? 3 For Your Watchlist 

What To Know About Buying Penny Stocks on April 26th With so many penny stocks to choose from, it can seem difficult to pick the best ones to buy. However, because there is such a large variety of small caps out there, finding ones that have the opportunity to be profitable, is complete...

AGRX - Agile Therapeutics stock gains on 1-for-40 reverse stock split

Agile Therapeutics (NASDAQ:AGRX) shares surged ~30% pre-market after the women's healthcare company announced a 1-for-40 reverse stock split, effective 5:00 p.m. on April 26, 2022. The move is expected to increase the per share trading price of the firm's common stock in order ...

AGRX - Agile Therapeutics Announces 1-For-40 Reverse Stock Split

PRINCETON, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women's healthcare company, today announced that the Board approved a 1-for-40 reverse stock split, to be effective 5:00 p.m. on Tuesday, April 26, 2022. The Company&#...

AGRX - Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Women's Health, Autism, Glaucoma, and Cancer Therapeutics

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Brickell Biotech (NASDAQ: BBI), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therape...

AGRX - Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit

Penny stocks are well known for their volatility. They’re also known for producing big wins for investors who are willing to take on high-risk trades. This week, the broader markets have gotten off to another choppy start, but that doesn’t seem to have become a concern for sma...

Previous 10 Next 10